Encompass Health Corporation/ US29261A1007 /
| 2024-04-18 10:10:00 PM | Chg. -1.07 | Volume | Bid1:00:00 PM | Ask1:00:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 78.62USD | -1.34% | 769,242 Turnover: 44.21 mill. |
67.85Bid Size: 100 | 125.00Ask Size: 100 | 7.87 bill.USD | 0.76% | 22.40 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 3.51 USD | 29.04% |
| EPS Diluted: | 3.47 USD | 28.52% |
| Revenues per Share: | 47.94 USD | 9.95% |
| Book Value per Share: | 22.52 USD | 22.98% |
| Cash Flow per Share: | 8.50 USD | 20.05% |
| Dividend per Share: | 0.60 USD | -30.23% |
| Total | in mill. | |
| Revenues: | 4,801.20 USD | 10.41% |
| Net Income: | 352.00 USD | 29.89% |
| Operating Cash Flow: | 850.80 USD | - |
| Cash and Cash Equivalents: | 69.10 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 22.40 | 19.01 |
| P/S Ratio: | 1.64 | 1.39 |
| P/BV ratio: | 3.49 | 2.96 |
| P/CF Ratio: | 9.25 | 7.85 |
| PEG: | 0.77 | 0.65 |
| Earnings Yield: | 4.46% | 5.26% |
| Dividend Yield: | 0.76% | 0.90% |
| Market Capitalization | ||
| Market Capitalization: | 7.87 bill. USD | 6.68 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 100.14 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | 0.00% |
| Net Profit Margin: | 7.33% |
| Return on Equity: | 15.61% |
| Return on Assets: | 5.77% |
Financial Strength
| Liquidity I / Cash Ratio: | 10.53% |
| Liquidity II / Quick Ratio: | 103.70% |
| Liquidity III / Current Ratio: | 128.25% |
| Debt / Equity Ratio: | 170.59% |
| Dynam. Debt / Equity Ratio: | 452.19% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
